Pages that link to "Q37372644"
Jump to navigation
Jump to search
The following pages link to Graeme J. Hankey (Q37372644):
Displaying 50 items.
- Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. (Q21034169) (← links)
- Older men who use computers have lower risk of dementia (Q21134062) (← links)
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition (Q24170269) (← links)
- Antithrombotic treatment after intracerebral haemorrhage (Q24185972) (← links)
- Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery (Q24202939) (← links)
- Selective serotonin reuptake inhibitors (SSRIs) for stroke (Q24235446) (← links)
- Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients (Q24240326) (← links)
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial (Q24595579) (← links)
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. (Q26782024) (← links)
- The Prognostic Significance of Right Bundle Branch Block: A Meta-analysis of Prospective Cohort Studies (Q26782100) (← links)
- The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus (Q26798104) (← links)
- Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis (Q27015758) (← links)
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 (Q28083357) (← links)
- Cyclooxygenase-2 inhibitors: are they really atherothrombotic, and if not, why not? (Q28165795) (← links)
- Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care (Q28166842) (← links)
- Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice (Q28167273) (← links)
- Aspirin resistance (Q28167475) (← links)
- Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness (Q28167713) (← links)
- Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure? (Q28168289) (← links)
- The beginning of the end of warfarin? (Q28168824) (← links)
- Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks (Q28174032) (← links)
- Non-valvular atrial fibrillation and stroke prevention. National Blood Pressure Advisory Committee of the National Heart Foundation (Q28181239) (← links)
- Review: dipyridamole given with or without aspirin reduces recurrent stroke (Q28182292) (← links)
- Preventable stroke and stroke prevention (Q28187602) (← links)
- Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke? (Q28193161) (← links)
- Aspirin for the primary prevention of cardiovascular events (Q28193873) (← links)
- Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial (Q28193982) (← links)
- Medical treatment of peripheral arterial disease (Q28194759) (← links)
- Aspirin resistance (Q28195157) (← links)
- Aspirin resistance: a new independent predictor of vascular events? (Q28195460) (← links)
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events (Q28195656) (← links)
- Anticoagulants versus antiplatelet agents for acute ischemic stroke (Q28196242) (← links)
- Antiplatelet drugs (Q28196263) (← links)
- Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial (Q28210537) (← links)
- Secondary prevention of recurrent stroke (Q28212778) (← links)
- Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines (Q28212949) (← links)
- Aspirin resistance (Q28218054) (← links)
- Atrial fibrillation (Q28219183) (← links)
- Potential new risk factors for ischemic stroke: what is their potential? (Q28249412) (← links)
- Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015 (Q28391248) (← links)
- Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study (Q28392340) (← links)
- Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data (Q28655857) (← links)
- Stroke: working toward a prioritized world agenda (Q28677503) (← links)
- Stroke: working toward a prioritized world agenda (Q28677657) (← links)
- Stroke: working toward a prioritized world agenda (Q28742458) (← links)
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (Q29614696) (← links)
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 (Q29616834) (← links)
- Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration (Q30234524) (← links)
- Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study (Q30252707) (← links)
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. (Q30353189) (← links)